1119-46-6O=C(O)CCCCClYSXDKDWNIPOSMF-UHFFFAOYSA-N5-chloropentanoic acid is an organochlorine compound comprising pentanoic acid with a 5-chloro substituent.
1119-46-6DTXSID60149767CHEBI:60701Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Warning
H315 (91.1%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 45 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
REACH registered substance: 5-chlorovaleric acid (EC: 214-279-3)
5-Chlorovaleric acid: Does not have an individual approval but may be used under an appropriate group standard
UsesLabelled α-Ergocryptine. α-Ergocryptine is an ergopeptine and one of the ergot alkaloids. An impurity of 2-Bromo-α-Ergocryptine Mesylate (B682600).
Uses5-Chlorovaleric acid was used to derivatize L-hydroxyproline for the synthesis of haptens HP1 and HP2. These haptens were used in the preparation of antibodies against L-hydroxyproline.
Preparation5-Chlorovaleric acid is obtained by reacting 1,4-dichlorobutane with potassium cyanide or sodium hydride using a phase transfer catalysis method to produce 5-chlorovalerate, which is then hydrolyzed in an acidic aqueous solution.
DefinitionChEBI: An organochlorine compound comprising pentanoic acid with a 5-chloro substituent.